Paternal HLA ‐Derived Epitopes and Live Birth in Secondary Recurrent Pregnancy Loss: New Insights From a Clinical Trial
HLA · 2024
DOI: 10.1111/tan.15723 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift HLA, 2024. Verfasst von Maria Christine Krog und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Recurrent Pregnancy Loss Units, The Capital Region, Copenhagen University Hospitals, Rigshospitalet and Hvidovre Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Abortion, Habitual, Epitopes, Live Birth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Svend Andersen Fonden, Rigshospitalet, Ferring Pharmaceuticals.
Abstract (Originalsprache)
Recurrent pregnancy loss (RPL), defined as two or more pregnancy losses before the 24th week of gestation, affects 1%–3% of women worldwide. Approximately, 40% of RPL cases are secondary RPL (sRPL), where women have given birth before facing pregnancy losses. The underlying causes of RPL remain unclear, but immune‐related factors may play a role. Previously, a randomised controlled trial using immunoglobulin (IVIG) in sRPL women with a history of four pregnancy losses performed in our RPL unit did not show significant effects of IVIG treatment overall. Yet, some evidence suggests potential benefits for a subset of sRPL patients. In the cohort used for the randomised controlled trial, we examined the role of maternal HLA class II‐presented fetal HLA‐derived epitopes in sRPL using the predicted indirectly recognisable HLA epitopes (PIRCHE‐II) algorithm. In the placebo group, sRPL mothers with an anti‐HLA antibody response had higher PIRCHE‐II scores when having a live birth compared with sRPL women who experienced another pregnancy loss. This difference was not observed in the IVIG‐treated group. Furthermore, as a proxy for T‐cell memory, the number of overlapping peptides between the two paternal haplotypes in couples having live births without treatment displayed a larger number of overlapping peptides. This effect was primarily driven by class II‐derived peptides. These results suggest that specific combinations of sRPL mothers and fathers, particularly those with an anti‐HLA antibody response, may generate higher PIRCHE‐II scores, which could contribute to successful live births. Understanding these immune interactions may provide insights for personalised diagnostic and therapeutic strategies in sRPL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Recurrent Pregnancy Loss Units, The Capital Region, Copenhagen University Hospitals, Rigshospitalet and Hvidovre Hospital, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
- Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Research and Development, PIRCHE AG, Berlin, Germany.
ORCID-Profile: Maria Christine Krog, Emma T M Peereboom, Henriette Svarre Nielsen, Eric Spierings
Förderung
- Svend Andersen Fonden
- Rigshospitalet
- Ferring Pharmaceuticals
- Ferring
Zitieren
APA
Krog, M. C., Peereboom, E. T. M., Geneugelijk, K., Matern, B. M., Kolte, A. M., Christiansen, O. B., Steffensen, R., Nielsen, H. S., & Spierings, E. (2024). Paternal HLA ‐Derived Epitopes and Live Birth in Secondary Recurrent Pregnancy Loss: New Insights From a Clinical Trial. HLA. https://doi.org/10.1111/tan.15723
Vancouver
Krog MC, Peereboom ETM, Geneugelijk K, Matern BM, Kolte AM, Christiansen OB, et al. Paternal HLA ‐Derived Epitopes and Live Birth in Secondary Recurrent Pregnancy Loss: New Insights From a Clinical Trial. HLA. 2024. doi:10.1111/tan.15723
BibTeX
@article{Krog2024,
author = {Krog, Maria Christine and Peereboom, Emma T M and Geneugelijk, Kirsten and Matern, Benedict M and Kolte, Astrid Marie and Christiansen, Ole Bjarne and Steffensen, Rudi and Nielsen, Henriette Svarre and Spierings, Eric},
title = {Paternal HLA ‐Derived Epitopes and Live Birth in Secondary Recurrent Pregnancy Loss: New Insights From a Clinical Trial},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15723}
}
EUVIMED